Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with (225)Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer

It has been proven and confirmed in numerous repeated tests, that the use of a combination of several therapeutic methods gives much better treatment results than in the case of separate therapies. Particularly promising is the combination of ionizing radiation and magnetic hyperthermia in one drug....

Descripción completa

Detalles Bibliográficos
Autores principales: Cędrowska, Edyta, Pruszyński, Marek, Gawęda, Weronika, Żuk, Michał, Krysiński, Paweł, Bruchertseifer, Frank, Morgenstern, Alfred, Karageorgou, Maria-Argyro, Bouziotis, Penelope, Bilewicz, Aleksander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179151/
https://www.ncbi.nlm.nih.gov/pubmed/32106568
http://dx.doi.org/10.3390/molecules25051025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179151/
https://www.ncbi.nlm.nih.gov/pubmed/32106568
http://dx.doi.org/10.3390/molecules25051025

Ejemplares similares